Bristol Myers Squibb will make even deeper cuts to its organization to enhance efficiencies as it faces the 2028 loss of exclusivity for its blockbuster drugs Eliquis and Opdivo 🩺💊 Click here for more information 👇 ℹ️ https://pharmanewspress.com/2025/02/bms-adds-2b-to-cost-cutting-plans-eyes-deals-after-cobenfy-success/